| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-07 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.35 | 6e-07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.23 | 1e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.22 | 6e-06 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-06 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |